Rallybio Corp (RLYB) Social Stream
RALLYBIO CORP (RLYB) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering RALLYBIO CORP.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-10 | 3 | $40 | $20 | $30 | $2.64 | 1036.36% |
| 2022-08-08 | 4 | $40 | $20 | $30.666 | $2.64 | 1061.59% |
| 2022-08-09 | 4 | $40 | $20 | $31.333 | $2.64 | 1086.86% |
| 2022-11-07 | 3 | $34 | $19 | $26.5 | $2.64 | 903.79% |
| 2022-12-09 | 4 | $34 | $19 | $24.666 | $2.64 | 834.32% |
| 2023-02-22 | 4 | $29 | $19 | $23 | $2.64 | 771.21% |
| 2023-03-06 | 4 | $29 | $16 | $22 | $2.64 | 733.33% |
| 2023-03-08 | 4 | $29 | $16 | $21.666 | $2.64 | 720.68% |
| 2023-04-10 | 5 | $29 | $16 | $20.5 | $2.64 | 676.52% |
| 2023-05-10 | 6 | $29 | $16 | $20 | $2.64 | 657.58% |
| 2023-06-26 | 6 | $29 | $16 | $19.2 | $2.64 | 627.27% |
| 2023-06-30 | 6 | $29 | $14 | $18.8 | $2.64 | 612.12% |
| 2023-08-09 | 6 | $18 | $14 | $16.2 | $2.64 | 513.64% |
| 2023-08-10 | 6 | $18 | $14 | $16.4 | $2.64 | 521.21% |
| 2023-11-10 | 6 | $18 | $7 | $14.4 | $2.64 | 445.45% |
The Trend in the Analyst Price Target
RLYB's average price target has moved down $4.4 over the prior 137 days.
Over the past 37 weeks, RLYB's average upside potential has been 282.21%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-22 | 4 | 29 | 19 | 23.0 | 7.48 | 207.49% |
| 2023-06-26 | 6 | 29 | 16 | 19.2 | 6.03 | 218.41% |
| 2023-06-30 | 6 | 18 | 14 | 16.2 | 5.66 | 186.22% |
| 2023-06-30 | 6 | 29 | 14 | 18.8 | 5.66 | 232.16% |
| 2023-08-10 | 6 | 18 | 14 | 16.4 | 5.60 | 192.86% |
RLYB Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 7 | 0 | 0 | 0 | 0 | 7 |
The Trend in the Broker Recommendations
RLYB's average broker recommendation rating improved by 0 over the prior 26 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, RALLYBIO CORP's upside potential (average analyst target price relative to current price) is greater than 2391.61% of them.
- RLYB has a higher number of analysts covering the stock than 495.37% of all US stocks.
- In the context of stocks in the small market cap category, RALLYBIO CORP's variance in analysts' estimates is lower than -1519.44% of them.
- RALLYBIO CORP's average analyst price target is higher than 924.14% of Healthcare stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to RALLYBIO CORP are IMRX, RANI, and CYBN.
View All Top Stocks by Price Target
Make investment decisions regarding RLYB using the data that counts. Try POWR Ratings for free.